GERICO11_Adjuvant systemic treatment for oestrogen-receptor (ER)-positive HER2-negative breast carcinoma in women over 70 according to Genomic Grade (GG): chemotherapy + endocrine treatment versus endocrine treatment. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) multicentre phase III trial
Active, not recruitingCTIS2024-516996-34-00
Unicanceroestrogen-receptor (ER)-positive HER2-negative breast carcinoma
Start: 2012-04-12Target: 1989Updated: 2024-10-31